Next Article in Journal
Previous Article in Journal
Mar. Drugs 2010, 8(12), 2871-2892; doi:10.3390/md8122871
Review

Potential Anti-HIV Agents from Marine Resources: An Overview

1
 and 1,2,*
Received: 8 October 2010; in revised form: 25 November 2010 / Accepted: 26 November 2010 / Published: 29 November 2010
View Full-Text   |   Download PDF [253 KB, uploaded 29 November 2010]   |   Browse Figures
Abstract: Human immunodeficiency virus (HIV) infection causes acquired immune deficiency syndrome (AIDS) and is a global public health issue. Anti-HIV therapy involving chemical drugs has improved the life quality of HIV/AIDS patients. However, emergence of HIV drug resistance, side effects and the necessity for long-term anti-HIV treatment are the main reasons for failure of anti-HIV therapy. Therefore, it is essential to isolate novel anti-HIV therapeutics from natural resources. Recently, a great deal of interest has been expressed regarding marine-derived anti-HIV agents such as phlorotannins, sulfated chitooligosaccharides, sulfated polysaccharides, lectins and bioactive peptides. This contribution presents an overview of anti-HIV therapeutics derived from marine resources and their potential application in HIV therapy.
Keywords: anti-HIV agents; AIDS; phlorotannins; marine resources anti-HIV agents; AIDS; phlorotannins; marine resources
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Vo, T.-S.; Kim, S.-K. Potential Anti-HIV Agents from Marine Resources: An Overview. Mar. Drugs 2010, 8, 2871-2892.

AMA Style

Vo T-S, Kim S-K. Potential Anti-HIV Agents from Marine Resources: An Overview. Marine Drugs. 2010; 8(12):2871-2892.

Chicago/Turabian Style

Vo, Thanh-Sang; Kim, Se-Kwon. 2010. "Potential Anti-HIV Agents from Marine Resources: An Overview." Mar. Drugs 8, no. 12: 2871-2892.



Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert